Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 153Breast 120Thoracic 93Genitourinary 78Gynecologic 64Head & Neck 50Tumor-Agnostic 48CNS 46Other hematologic neoplasm 45Lymphoid 45Dermatologic 45Sarcoma 33Plasma cell 22Myeloid 21Other solid neoplasm 11Endocrine 10Other 5Classical hematology 4NET 3Other neoplasm 2

Conditions

Neuroendocrine Tumors 2Midgut Neuroendocrine Tumors 1

Interventions

lutetium Lu 177 dotatate 32Everolimus 19Magnetic Resonance Spectroscopy 14gallium Ga 68 dotatate 12Temozolomide 12Nivolumab 11Capecitabine 10pembrolizumab 9lanreotide 9cabozantinib 8Positron Emission Tomography Computed Tomography 8177Lu-octreotide, DOTA(0)-Tyr(3)- 8Ga(III)-DOTATOC 73-Iodobenzylguanidine 7Somatostatin 6Octreotide 6Lutetium-177 6Carboplatin 690Y-octreotide, DOTA-Tyr(3)- 6telotristat ethyl 5surufatinib 5lenvatinib 5Ipilimumab 5Fluorodeoxyglucose F18 5pasireotide 4copper dotatate CU-64 4avelumab 4Single Photon Emission Computed Tomography Computed Tomography 4Positron-Emission Tomography 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Blood Specimen Collection × NET × Clear all
NCT06430021 2026-05-22

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Recruiting
297 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed
47 enrolled
EndocrineNET

Midgut Neuroendocrine Tumors

NCT02348749 2025-03-19

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
48 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡